Literature DB >> 17417778

Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.

Clemens Schafmayer1, Stephan Buch, Jan Hendrik Egberts, Andre Franke, Mario Brosch, Abdou El Sharawy, Mareike Conring, Maralde Koschnick, Sven Schwiedernoch, Alexander Katalinic, Bernd Kremer, Ulrich R Fölsch, Michael Krawczak, Fred Fändrich, Stefan Schreiber, Jürgen Tepel, Jochen Hampe.   

Abstract

Mutations in DNA repair genes have previously been identified as causative factors for hereditary nonpolyposis colon cancer (HNPCC). Recent evidence also supports an association between DNA sequence variation in these genes and sporadic colorectal carcinoma (CRC). Genetic investigation of DNA repair genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1, as possible susceptibility factors for sporadic CRC, was done using both a haplotype tagging and a candidate (i.e. coding) single nucleotide polymorphism (SNP) approach. Some 1,068 patients with operated CRC (median age at diagnosis: 59 years) were compared to 738 sex-matched control individuals (median age: 67 years). Haplotype tagging SNPs, previously reported risk variants and all known coding SNPs with a minor allele frequency >0.005 were genotyped in PMS2 (N = 10), MLH1 (N = 11), MSH2 (N = 18), MSH6 (N = 15), MUTYH (N = 7), OGG1 (N = 11) and MTH1 (N = 3). No evidence for an association between CRC and any of the 7 genes was detected, neither with the tagging or coding SNPs nor in a sliding window haplotype analysis (all nominal p-values >0.05). The previously reported risk variants D132H in MLH1 and R154H in OGG1 were not even observed in the German population. Genetic CRC risk factors so far identified in DNA repair genes seem to be rare and population-specific. Their association with the disease could not be replicated in German CRC samples. It remains to be elucidated by more systematic, large-scale experiments whether common variants in the same genes, but present across populations, represent risk factors for sporadic CRC. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17417778     DOI: 10.1002/ijc.22735

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Radiation risks associated with serial imaging in colorectal cancer patients: should we worry?

Authors:  Jeong Suk Oh; Jonathan B Koea
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

2.  Mutation deep within an intron of MSH2 causes Lynch syndrome.

Authors:  Mark Clendenning; Daniel D Buchanan; Michael D Walsh; Belinda Nagler; Christophe Rosty; Bryony Thompson; Amanda B Spurdle; John L Hopper; Mark A Jenkins; Joanne P Young
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

3.  A human functional protein interaction network and its application to cancer data analysis.

Authors:  Guanming Wu; Xin Feng; Lincoln Stein
Journal:  Genome Biol       Date:  2010-05-19       Impact factor: 13.583

4.  Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohort.

Authors:  Ceres Fernández-Rozadilla; Luisa de Castro; Juan Clofent; Alejandro Brea-Fernández; Xavier Bessa; Anna Abulí; Montserrat Andreu; Rodrigo Jover; Rosa Xicola; Xavier Llor; Antoni Castells; Sergi Castellví-Bel; Angel Carracedo; Clara Ruiz-Ponte
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

5.  Hypoxia-inducible factor-1 modulates upregulation of mutT homolog-1 in colorectal cancer.

Authors:  Yuan Qiu; Hong Zheng; Li-Hua Sun; Ke Peng; Wei-Dong Xiao; Hua Yang
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

6.  Genome-wide investigation of gene-environment interactions in colorectal cancer.

Authors:  Sabine Siegert; Jochen Hampe; Clemens Schafmayer; Witigo von Schönfels; Jan-Hendrik Egberts; Asta Försti; Bowang Chen; Jesús Lascorz; Kari Hemminki; Andre Franke; Michael Nothnagel; Ute Nöthlings; Michael Krawczak
Journal:  Hum Genet       Date:  2012-11-02       Impact factor: 4.132

7.  MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.

Authors:  Morteza Gholami; Bagher Larijani; Farshad Sharifi; Shirin Hasani-Ranjbar; Reza Taslimi; Milad Bastami; Rasha Atlasi; Mahsa M Amoli
Journal:  Cancer Med       Date:  2019-10-21       Impact factor: 4.452

8.  COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.

Authors:  I P M Tomlinson; M Dunlop; H Campbell; B Zanke; S Gallinger; T Hudson; T Koessler; P D Pharoah; I Niittymäki; I Niittymäkix; S Tuupanen; S Tuupanenx; L A Aaltonen; K Hemminki; A Lindblom; A Försti; O Sieber; L Lipton; T van Wezel; H Morreau; J T Wijnen; P Devilee; K Matsuda; Y Nakamura; S Castellví-Bel; C Ruiz-Ponte; A Castells; A Carracedo; J W C Ho; P Sham; R M W Hofstra; P Vodicka; H Brenner; J Hampe; C Schafmayer; J Tepel; S Schreiber; H Völzke; M M Lerch; C A Schmidt; S Buch; V Moreno; C M Villanueva; P Peterlongo; P Radice; M M Echeverry; A Velez; L Carvajal-Carmona; R Scott; S Penegar; P Broderick; A Tenesa; R S Houlston
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

9.  Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancer.

Authors:  Ian P M Tomlinson; Richard S Houlston; Grant W Montgomery; Oliver M Sieber; Malcolm G Dunlop
Journal:  Mutagenesis       Date:  2012-03       Impact factor: 3.000

10.  Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers.

Authors:  Sabine Siegert; Zhonghao Yu; Rui Wang-Sattler; Thomas Illig; Jerzy Adamski; Jochen Hampe; Susanna Nikolaus; Stefan Schreiber; Michael Krawczak; Michael Nothnagel; Ute Nöthlings
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.